Recursion Pharmaceuticals, Inc.
USD3.69
-0.01 (-0.14%)
CEO
Najat Khan
IPO Date
2021-04-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.68
Prev. Close
$3.69
Day Low
$3.61
Day High
$3.71
52W Low
$2.77
52W High
$7.18
Market Cap
$1.65B
Volume
3.88M
| -4.0 |
| 31 Dec 2023 | FY | 2.9% | -747.7% | -70.8% | -50.2% | 0.11 | 4.70 | -6.2 |
| 31 Dec 2022 | FY | -21.7% | -603.5% | -49.3% | -34.1% | 0.10 | 5.68 | -5.7 |
| 31 Dec 2021 | FY | 100.0% | -1864.8% | -34.3% | -30.6% | 0.02 | 11.46 | -15.6 |
| 31 Dec 2020 | FY | 100.0% | -2549.3% | 42.2% | -29.1% | -0.08 | 11.53 | -34.3 |
| 31 Dec 2019 | FY | -2577.3% | -3654.3% | 50.3% | -61.6% | -0.13 | 11.43 | -47.7 |
| -5.0 |
| 30 Sept 2025 | Q3 | -471.8% | -3135.3% | -15.5% | -11.6% | 0.08 | 4.60 | -3.4 |
| 30 Jun 2025 | Q2 | -5.5% | -899.8% | -18.7% | -13.2% | 0.10 | 3.58 | -3.1 |
| 31 Mar 2025 | Q1 | -48.0% | -1373.3% | -21.7% | -15.5% | 0.10 | 4.11 | -2.6 |
| 31 Dec 2024 | Q4 | -183.6% | -3966.0% | -17.3% | -12.4% | 0.10 | 3.81 | -3.2 |
| 30 Sept 2024 | Q3 | 53.7% | -366.8% | -18.2% | -13.2% | 0.17 | 4.35 | -4.9 |
| 30 Jun 2024 | Q2 | 36.1% | -677.2% | -16.7% | -12.6% | 0.15 | 6.07 | -4.6 |
| 31 Mar 2024 | Q1 | 17.2% | -677.3% | -22.8% | -16.4% | 0.13 | 4.65 | -6.1 |
| 31 Dec 2023 | Q4 | 7.0% | -875.3% | -20.1% | -14.2% | 0.11 | 4.70 | -6.2 |